selected publications
- Type II kinase inhibitors that target Parkinson's disease-associated LRRK2. Science advances. 2025 Academic Article GET IT
- Type-II kinase inhibitors that target Parkinson's Disease-associated LRRK2. 2025 GET IT
-
Molecular architecture of the autoinhibited kinesin-1 lambda particle.
Science advances.
2022
Academic Article
GET IT
Times cited: 16 -
In situ cryo-electron tomography reveals filamentous actin within the microtubule lumen.
The Journal of cell biology.
2020
Academic Article
GET IT
Times cited: 25